Changes in retinal nonperfusion associated with suppression of vascular endothelial growth factor in retinal vein occlusion

Ophthalmology

Volumn 123, Issue 3, 2016, Pages 625-634.e1

  Mir, Tahreem A ^a   Kherani, Saleema ^a   Hafiz, Gulnar ^a   Scott, Adrienne W ^a   Zimmer Galler, Ingrid ^a   Wenick, Adam S ^a   Solomon, Sharon ^a   Han, Ian ^a   Poon, David ^a   He, Lingmin ^a   Shah, Syed Mahmood ^a   Brady, Christopher J ^a   Meyerle, Catherine ^a   Sodhi, Akrit ^a   Linz, Marguerite O ^a   Sophie, Raafay ^a   Campochiaro, Peter A ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RANIBIZUMAB; VASCULOTROPIN; ANGIOGENESIS INHIBITOR; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; HUMAN; IMAGING SYSTEM; LASER COAGULATION; MAJOR CLINICAL STUDY; PERFUSION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETINA FLUORESCEIN ANGIOGRAPHY; RETINA VEIN OCCLUSION; RETINAL NONPERFUSION; TREATMENT OUTCOME; AGED; ANTAGONISTS AND INHIBITORS; BLOOD FLOW; COMPARATIVE STUDY; DRUG EFFECTS; FEMALE; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; INTRAVITREAL DRUG ADMINISTRATION; MALE; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; OPTICAL COHERENCE TOMOGRAPHY; PATHOPHYSIOLOGY; PHYSIOLOGY; RETINA VEIN; RETINAL VEIN OCCLUSION; VISUAL ACUITY;

AGED; ANGIOGENESIS INHIBITORS; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; DOUBLE-BLIND METHOD; FEMALE; FLUORESCEIN ANGIOGRAPHY; FOLLOW-UP STUDIES; HUMANS; INTRAVITREAL INJECTIONS; LASER COAGULATION; MALE; MIDDLE AGED; RANIBIZUMAB; REGIONAL BLOOD FLOW; RETINAL VEIN; RETINAL VEIN OCCLUSION; TOMOGRAPHY, OPTICAL COHERENCE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY;

EID: 84959484549     PISSN: 01616420     EISSN: 15494713     Source Type: Journal    
DOI: 10.1016/j.ophtha.2015.10.030     Document Type: Article

References (14)

1. P.A. Campochiaro, G. Hafiz, S.M. Shah, and et al. Ranibizumab for macular edema due to retinal vein occlusions: implication of VEGF as a critical stimulator Mol Ther 16 2008 791 799
2. P.A. Campochiaro, J.S. Heier, L. Feiner, and et al. Ranibizumab for macular edema following branch retinal vein occlusion: 6-month primary end point results of a phase III study Ophthalmology 117 2010 1102 1112
3. D.M. Brown, P.A. Campochiaro, R.P. Singh, and et al. Efficacy and safety of ranibizumab in the treatment of macular edema secondary to central retinal vein occlusion: 6-month results of the phase III CRUISE study Ophthalmology 117 2010 1124 1133
4. J.S. Heier, W.L. Clark, D.S. Boyer, and et al. Intravitreal aflibercept injection for macular edema due to central retinal vein occlusion: two-year results from the COPERNICUS study Ophthalmology 121 2014 1414 1420
5. D.M. Brown, P.A. Campochiaro, R.B. Bhisitkul, and et al. Sustained benefits from ranibizumab for macular edema following branch retinal vein occlusion: 12-month outcomes of a phase III study Ophthalmology 118 2011 1594 1602
6. P.A. Campochiaro, D.M. Brown, C.C. Awh, and et al. Sustained benefits from ranibizumab for macular edema following central retinal vein occlusion: 12-month outcomes of a phase III study Ophthalmology 118 2011 2041 2049
7. P.A. Campochiaro, R.B. Bhistikul, H. Shapiro, and R.G. Rubio Vascular endothelial growth factor promotes progressive retinal nonperfusion in patients with retinal vein occlusion Ophthalmology 120 2013 795 802
8. P.A. Campochiaro, G. Hafiz, T.A. Mir, and et al. Scatter photocoagulation does not reduce macular edema or treatment burden in patients with retinal vein occlusion: the RELATE trial Ophthalmology 122 2015 1426 1437
9. The SCORE Study Research Group A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular edema secondary to branch vein occlusion. The standard care vs corticosteroid for retinal vein occlusion (SCORE) study report 6 Arch Ophthalmol 127 2009 1115 1128
10. The SCORE Study Research Group A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion. The Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 5 Arch Ophthalmol 127 2009 1101 1114
11. R. Sophie, G. Hafiz, A. Scott, and et al. Long term outcomes in ranibizumab-treated patients with retinal vein occlusion; the role of progression of retinal nonperfusion Am J Ophthalmol 156 2013 693 705
12. The Branch Vein Occlusion Study. Argon laser photocoagulation for macular edema in branch vein occlusion Am J Ophthalmol 98 1984 271 282
13. The Central Vein Occlusion Study Group Evaluation of grid pattern photocoagulation for macular edema in central vein occlusion. The central vein occlusion study group M report Ophthalmology 102 1995 1425 1433
14. The Central Vein Occlusion Study Group Natural history and clinical management of central retinal vein occlusion. The Central Vein Occlusion Study Group Arch Ophthalmol 115 1997 486 491